A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
NCT06857942
This study is recruiting at 39 US sites in 22 states, according to its ClinicalTrials.gov record last updated .
Summary
The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Psoriasis
- Overweight or Obesity
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Eli Lilly and Company
- Last updated on ClinicalTrials.gov
- September 4, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Medical Dermatology Specialists · Phoenix, AZ
California · 4
- First OC Dermatology Research Inc · Fountain Valley, CA
- Center For Dermatology Clinical Research, Inc. · Fremont, CA
- Metropolis Dermatology · Los Angeles, CA
- Northridge Clinical Trials · Northridge, CA
Florida · 5
- NeoClinical Research · Hialeah, FL
- Encore Medical Research · Hollywood, FL
- Skin Care Research · Hollywood, FL
- MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research · Tampa, FL
- TruDerm & TruSpa · Wellington, FL
Georgia · 1
- Southeast Research Specialists · Douglasville, GA
Indiana · 2
- Dawes Fretzin Clinical Research Group, LLC · Indianapolis, IN
- The Indiana Clinical Trials Center, PC · Plainfield, IN
Kentucky · 1
- Equity Medical - Bowling Green · Bowling Green, KY
Maryland · 1
- Dermatology and Skin Cancer Specialists, LLC · Rockville, MD
Massachusetts · 1
- Metro Boston Clinical Partners · Brighton, MA
Michigan · 2
- David Fivenson, MD, PLC · Ann Arbor, MI
- The Derm Institute of West Michigan · Caledonia, MI
Nevada · 1
- Skin Cancer and Dermatology Institute - Reno · Reno, NV
New Hampshire · 1
- Stracskin · Portsmouth, NH
New Jersey · 2
- Psoriasis Treatment Center of Central New Jersey · East Windsor, NJ
- Care Access - Hoboken · Hoboken, NJ
New York · 1
- Equity Medical · New York, NY
North Carolina · 2
- Revival Research Institute, LLC · Cary, NC
- Onsite Clinical Solutions - Huntersville · Huntersville, NC
Ohio · 1
- Optima Research - Boardman · Boardman, OH
Oregon · 1
- Oregon Dermatology and Research Center · Portland, OR
Pennsylvania · 1
- Dermatology Associates of Plymouth Meeting · Plymouth Meeting, PA
South Carolina · 1
- Columbia Dermatology & Aesthetics · Columbia, SC
Tennessee · 1
- DelRicht Research - Thompson's Station · Smyrna, TN
Texas · 6
- Bellaire Dermatology Associates · Bellaire, TX
- Modern Research Associates, PLLC · Dallas, TX
- Center for Clinical Studies · Houston, TX
- Austin Institute for Clinical Research · Pflugerville, TX
- Texas Dermatology and Laser Specialists · San Antonio, TX
- Center for Clinical Studies · Webster, TX
Utah · 1
- Tanner Clinic · Layton, UT
Washington · 2
- Bellevue Dermatology Clinic · Bellevue, WA
- Dermatology of Seattle · Burien, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.